Version 5.4
Homo sapiens Protein: TMEM132E
Summary
InnateDB Protein IDBP-40833.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol TMEM132E
Protein Name transmembrane protein 132E
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000316532
InnateDB Gene IDBG-40831 (TMEM132E)
Protein Structure
UniProt Annotation
Function
Subcellular Localization Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.
Disease Associations Note=TMEM132E is located in a region involved in a heterozygous deletion of approximately 4.7 Mb; this deletion, involving the NF1 gene and contiguous genes lying in its flanking regions, is observed in a patient 17q11.2 microdeletion syndrome, a syndrome characterized by variable facial dysmorphism, mental retardation, developmental delay, and an excessive number of neurofibromas. {ECO:0000269PubMed:14569139}.
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
Biological Process
Cellular Component
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro
PFAM
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q6IEE7
PhosphoSite PhosphoSite-Q6IEE7
TrEMBL
UniProt Splice Variant
Entrez Gene 124842
UniGene Hs.310482
RefSeq NP_997196
HUGO HGNC:26991
OMIM
CCDS CCDS11283
HPRD 14030
IMGT
EMBL AC005691 BC018318 BC020591 BN000149
GenPept AAH18318 AAH20591 CAD80169

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca